Angelman Syndrome
It is a genetic disorder which causes developmental disabilities and nerve related symptoms.
Symptoms include lack of crawling or babbling, minimal speech and frequent smiling and laughter. Inability to walk, move or balance well (ataxia) is also a symptom. Treatment includes anti-seizure medication and therapies to help manage medical and developmental concerns.
- 19,000+ cases of Angelman syndrome diagnosed in USA itself in 2017
- 1,000+ patents published related to Angelman Syndrome in last 10 years
- 150+ active organizations in Angelman Syndrome domain
- Major Players: Ovid Therapeutics, GeneTx, PTC Therapeutics, StrideBio and others.
